Viewing Study NCT01245556


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
Study NCT ID: NCT01245556
Status: COMPLETED
Last Update Posted: 2013-06-12
First Post: 2010-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module